Mersana Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Mersana Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Mersana Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Mersana Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $8.4M | 4.5M | 1.89 |
| 2024-06-30 | $5.6M | 2.8M | 2.01 |
| 2024-03-31 | $16M | 3.5M | 4.48 |
| 2023-12-31 | $4.6M | 2.0M | 2.32 |
| 2023-09-30 | $2.2M | 1.8M | 1.27 |
| 2023-06-30 | $880k | 267k | 3.29 |
| 2023-03-31 | $528k | 128k | 4.11 |
| 2022-12-31 | $3.7M | 630k | 5.86 |
| 2022-06-30 | $1.7M | 365k | 4.64 |
| 2022-03-31 | $2.8M | 714k | 3.99 |
| 2021-12-31 | $2.2M | 354k | 6.22 |
| 2021-09-30 | $1.1M | 112k | 9.44 |
| 2021-06-30 | $8.3M | 611k | 13.57 |
| 2021-03-31 | $10M | 643k | 16.17 |
| 2020-12-31 | $56M | 2.1M | 26.61 |
| 2020-09-30 | $8.8M | 472k | 18.62 |
| 2020-06-30 | $15M | 632k | 23.40 |
| 2020-03-31 | $2.7M | 461k | 5.83 |
| 2019-12-31 | $1.3M | 220k | 5.73 |
| 2019-09-30 | $147k | 93k | 1.58 |
| 2019-06-30 | $326k | 81k | 4.04 |
| 2019-03-31 | $246k | 47k | 5.29 |
| 2018-12-31 | $201k | 49k | 4.09 |
| 2017-06-30 | $179k | 13k | 13.96 |